Drug Updates - Archives

View previous drug approvals from the Food and Drug Administration (FDA).

Search

May 2017

Each month the FDA approves new medications, and below is a highlight of the most relevant new approvals and/or drugs which have the potential to impact your prescription plan.

DOWNLOAD FULL ARTICLE (PDF)

March 2017

Each month the FDA approves new medications, and below is a highlight of the most relevant new approvals and/or drugs which have the potential to impact your prescription plan.

DOWNLOAD FULL ARTICLE (PDF)

February 2017

Each month, the FDA approves new drugs. MedTrakRx likes our Plan Sponsors to be up to date on the latest drug approvals.

January 2017

Each month the FDA approves new medications, and below is a highlight of the most relevant new approvals and/or drugs which have the potential to impact your prescription plan.

December 2016

Each month the FDA approves new medications, and below is a highlight of the most relevant new approvals and/or drugs which have the potential to impact your prescription plan.

DOWNLOAD FULL ARTICLE (PDF)

November 2016

Each month the FDA approves new medications, and below is a highlight of the most relevant new approvals and/or drugs which have the potential to impact your prescription plan.

September 2016

Each month the FDA approves new medications, and below is a highlight of the most relevant new approvals and/or drugs which have the potential to impact your prescription plan.

DOWNLOAD FULL ARTICLE (PDF)

August 2016

Each month, MedTrakRx reviews the recently approved drugs.

July 2016

Each month the FDA approves new medications, and below is a highlight of the most relevant new approvals and/or drugs which have the potential to impact your prescription plan.

DOWNLOAD FULL ARTICLE (PDF)

June 2016

Zinbryta® entered the drug market as a treatment for adult patients with relapsing forms of multiple sclerosis (MS).

May 2016

Each month the FDA approves new medications, and below is a highlight of the most relevant new approvals and/or drugs which have the potential to impact your prescription plan.

DOWNLOAD FULL ARTICLE (PDF)

April 2016

Taltz® is a new treatment option for moderate to severe plaque psoriasis in adults.

DOWNLOAD FULL ARTICLE (PDF)

March 2016

Rosuvastatin zinc which is used for the treatment of various dyslipidemias, has been recently approved for the drug market. This is a new salt form of rosuvastatin.

DOWNLOAD FULL ARTICLE (PDF)

February 2016

Zepatier, the new treatment option for chronic Hepatitis C genotypes 1 and 2 will be entering the drug market for 2016.

DOWNLOAD FULL ARTICLE (PDF)

January 2016

Basaglar, the new long-acting insulin glargine for the treatment of type 1 and type 2 diabetes is set to hit the drug market in December of 2016. Although pricing information is not available at this time, it is a similar product to Sanofi's Lantus.

DOWNLOAD FULL ARTICLE (PDF)

December 2015

Several new specialty medications have been approved: one for the treatment of asthma, an HIV medication and two new chemotherapy agents.

DOWNLOAD FULL ARTICLE (PDF)

November 2015

Vivlodex is a new NSAID medication indicated for the management of osteoarthritis (OA) pain. This drug carries a black box warning regarding cardiovascular and gastrointestinal risk (similar to other NSAIDS).

DOWNLOAD FULL ARTICLE (PDF)

October 2015

Tresiba is a new medication that has been approved as a long-acting insulin analog indicated to improve glycemic control in adults with diabetes mellitus.

DOWNLOAD FULL ARTICLE (PDF)

September 2015

The FDA approves new medications each month, and it's important to provide you with the latest information so you can stay up to date on your current medications!

DOWNLOAD FULL ARTICLE (PDF)

August 2015

Entresto is the first agent in a new drug class used in the treatment of heart failure. The FDA granted approval six weeks ahead of schedule because it significantly reduced the risk of cardiovascular death in clinical trails. Learn more here!

July 2015

The FDA has approved Desvenlafaxine succinate, the first generic alternative to Pristiq available on the market used for the treatment of major depressive disorder. Continue reading to find out more.

DOWNLOAD FULL ARTICLE (PDF)
Search Drug Updates